单步复苏法用于囊胚:临床验证的多步法替代方案
本研究在单中心IVF中心分三阶段验证单步复苏囊胚方案:风险分析、临床前验证(n=246囊胚)及一年临床回顾比较(单步1925周期 vs 多步1744周期)。单步组囊胚存活率、完整率及移植率更高,持续妊娠率相当,流产率呈一致下降趋势。
要点
- 单步复苏囊胚完整率显著高于多步法(85.4% vs 76.3%)。
- 单步复苏在多个亚组中存活率显著更高,持续妊娠率无差异。
- 单步法可简化流程,且不损害临床结局。
核心结论
- 单步复苏方案是临床验证的安全高效替代方案,可简化囊胚处理流程而不影响临床结局。
研究设计与样本
- 单中心三阶段验证研究:风险分析、临床前验证(n=246囊胚)及一年临床回顾比较(单步1925周期 vs 多步1744周期)。
主要发现
- 临床前阶段单步组完整囊胚率85.4% vs 多步76.3%(P=0.0058),移植适宜率96.7% vs 91.2%(P=0.0076)。
- 临床队列中非PGT第5天囊胚存活率98.5% vs 96.1%(P=0.0003),PGT第5天100% vs 98.2%(P=0.0407)。
- 持续妊娠率在各亚组均无显著差异,流产率呈一致下降趋势但未达统计显著。
关键数值与推荐
- 存活定义为≥50%完整细胞,完整定义为100%完整。
- 单步组再扩张率93.9%,平均再扩张时间3.3±2.7小时。
- 荧光活性染色显示90.5%囊胚无或极少细胞损伤。
临床怎么用
- 可考虑将单步复苏作为常规多步法的替代方案以优化工作流程。
- 单步复苏后囊胚完整性和移植适宜性更高,尤其适用于非PGT第5天和PGT第5天囊胚。
局限性
- 单中心研究,对照组为回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can a single-step warming protocol for vitrified blastocysts provide comparable or superior outcomes to a conventional multi-step warming approach in a clinical IVF setting? SUMMARY ANSWER: Single-step warming resulted in higher blastocyst survival, intactness, and transfer rates compared to the conventional multi-step protocol, with comparable ongoing pregnancy rates and a consistent trend toward lower miscarriage rates across all subgroups. WHAT IS KNOWN ALREADY: While vitrification has become the gold standard for embryo cryopreservation, the warming process remains critical to embryo survival and implantation potential. Traditional warming relies on multi-step dilution protocols to minimize osmotic stress. Preliminary studies have suggested that single-step rehydration protocols may be equally effective, but data on clinical validation remain scarce. STUDY DESIGN, SIZE, DURATION: A three-phase validation study was conducted at a single university-based IVF centre including (i) risk analysis, (ii) preclinical validation (n = 246 blastocysts), and (iii) a clinical comparison of outcomes over one year (March 2024-March 2025) between single-step warming (n = 1925 cycles) and the conventional multi-step protocol (n = 1744 cycles, March 2023-March 2024). PARTICIPANTS/MATERIALS, SETTING, METHODS: In the preclinical phase, vitrified surplus and PGT blastocysts were rewarmed using the single-step protocol and compared to historical controls. Survival (≥50% intact cells), intactness (100% intact), and transfer suitability were assessed. Single-step warmed blastocysts were monitored for 24 h post-warming in a time-lapse incubator, and viability was further evaluated using live/dead fluorescent staining to quantify cell damage. In the clinical phase, outcomes (survival, transfer rate, pregnancy, ongoing pregnancy, miscarriage) were retrospectively compared across protocols, stratified by PGT status and day of vitrification. MAIN RESULTS AND THE ROLE OF CHANCE: In the preclinical phase, blastocyst survival was ≥50% in 99.1% of cases after single-step warming versus 96.8% after multi-step warming (P = 0.0924). Fully intact blastocysts were significantly more frequent in the single-step group (85.4% vs. 76.3%, P = 0.0058), and transfer suitability at 2 h post-warming was also higher (96.7% vs. 91.2%, P = 0.0076). Time-lapse monitoring confirmed a high re-expansion rate (93.9%) with a mean re-expansion time of 3.3 ± 2.7 h. Fluorescent viability staining showed that 90.5% of blastocysts exhibited no or minimal cell damage. In the clinical cohort, significantly higher survival rates were seen in the single-step group across multiple subgroups, including non-PGT Day 5 (98.5% vs. 96.1%, P = 0.0003) and PGT Day 5 (100% vs. 98.2%, P = 0.0407) blastocysts. Fully intact rates were significantly higher in all subgroups and transfer rates were significantly higher in the single-step group for non-PGT Day 6 (97.2% vs. 92.8%, P = 0.0060) and PGT Day 5 cycles (100% vs. 97.8%, P = 0.0209). While some early pregnancy outcomes (e.g. clinical pregnancy in non-PGT Day 5) favoured the multi-step protocol (40.5% vs. 35.7%, P = 0.0286), ongoing pregnancy rates were not significantly different in any subgroup. Miscarriage rates showed a consistent trend in favour of single-step warming but did not reach statistical significance. LIMITATIONS, REASONS FOR CAUTION: This was a single-centre study, and the control group was retrospective. WIDER IMPLICATIONS OF THE FINDINGS: The single-step warming protocol is a clinically validated, safe, and efficient alternative to conventional multi-step warming. Its implementation may improve workflow and streamline blastocyst handling without compromising clinical outcomes. STUDY FUNDING/COMPETING INTEREST(S): No external funding was received. The authors declare no conflicts of interest apart from KT, who has received travel support related to the manuscript from Fuijifilm Irvine Scientific, in the form of payment to her institution. TRIAL REGISTRATION NUMBER: N/A.
引用
- De Gheselle S, De Vuyst L, Lierman S, et al. Single-step warming for blastocysts: a clinically validated alternative to conventional multi-step protocols. Hum Reprod. 2026. PMID: 41701553. doi:10.1093/humrep/deag021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。